LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma.

    Stammler, Romain / Ta, Van Anh / Cohen, Elisabeth / Ram-Wolff, Caroline / Bozonnat, Alizée / Battesti, Gilles / Louveau, Baptiste / Mourah, Samia / Battistella, Maxime / Moins-Teisserenc, Hélène / de Masson, Adèle

    The British journal of dermatology

    2024  

    Language English
    Publishing date 2024-02-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1093/bjd/ljae085
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: CD39 is expressed by a wide range of cutaneous T-cell lymphomas.

    Battesti, Gilles / Thonnart, Nicolas / Bozonnat, Alizée / Ram-Wolff, Caroline / de Masson, Adèle / Bensussan, Armand / Bagot, Martine / Marie-Cardine, Anne / Battistella, Maxime

    Skin health and disease

    2024  Volume 4, Issue 2, Page(s) e334

    Abstract: CD39, an ectoenzyme in the immunosuppressive CD39/CD73/adenosine pathway, known to promote solid tumour outgrowth and spreading, was investigated in both skin and blood compartments of cutaneous T cell lymphomas. CD39 was overexpressed by peripheral ... ...

    Abstract CD39, an ectoenzyme in the immunosuppressive CD39/CD73/adenosine pathway, known to promote solid tumour outgrowth and spreading, was investigated in both skin and blood compartments of cutaneous T cell lymphomas. CD39 was overexpressed by peripheral blood T-cells in Sezary syndrome and mycosis fungoides, and in skin-infiltrating lymphocytes of Sezary syndrome, mycosis fungoides, subcutaneous panniculitis-like T-cell lymphoma and primary cutaneous CD30-positive lymphoproliferation. Our study emphasizes the interest in using CD39/CD73/adenosine pathway blocking agents for cutaneous T cell lymphomas treatment.
    Language English
    Publishing date 2024-01-10
    Publishing country England
    Document type Journal Article
    ISSN 2690-442X
    ISSN (online) 2690-442X
    DOI 10.1002/ski2.334
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome.

    Ranjbaryan, Merian / Calvani, Julien / Louveau, Baptiste / Cuccuini, Wendy / Battesti, Gilles / Bozonnat, Alizée / Moins-Teisserenc, Hélène / Michonneau, David / Bagot, Martine / Ram-Wolff, Caroline / Dobos, Gabor / Mourah, Samia / Battistella, Maxime / de Masson, Adèle

    European journal of dermatology : EJD

    2023  Volume 33, Issue 4, Page(s) 439–440

    MeSH term(s) Humans ; Sezary Syndrome/pathology ; Skin/pathology ; Hematopoietic Stem Cell Transplantation/adverse effects ; Lymphoma ; Skin Neoplasms/etiology ; Graft vs Host Disease/etiology
    Language English
    Publishing date 2023-10-12
    Publishing country France
    Document type Journal Article
    ZDB-ID 1128666-0
    ISSN 1952-4013 ; 1167-1122
    ISSN (online) 1952-4013
    ISSN 1167-1122
    DOI 10.1684/ejd.2023.4522
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Prevalence, characteristics, and knowledge related to photosensitivity in patients with lupus erythematosus: the international PHOTOLUP study.

    Battesti, Gilles / Felten, Renaud / Piga, Matteo / Sarmiento-Monroy, Juan C / Ziade, Nelly / El Kibbi, Lina / Ugarte-Gil, Manuel / Arnaud, Laurent / Chasset, François

    Rheumatology (Oxford, England)

    2023  

    Abstract: Objectives: To assess the prevalence, characteristics and knowledge about photosensitivity and the use of photoprotective measures in an international cohort of cutaneous and systemic lupus erythematosus patients.: Methods: We conducted an ... ...

    Abstract Objectives: To assess the prevalence, characteristics and knowledge about photosensitivity and the use of photoprotective measures in an international cohort of cutaneous and systemic lupus erythematosus patients.
    Methods: We conducted an international, cross-sectional study based on a 46-question web-based survey including patients with medically confirmed LE conducted between November 2021 and April 2022.
    Results: 600 patients with lupus erythematosus (94% female, median age: 41 years [IQR: 33-51]) from 50 countries were included. A history of photosensitivity was reported by 389/600 (64.8%) patients. Photosensitivity was associated with the presence of other cutaneous involvement (OR = 3.8; 95%CI 2.5-5.7; p < 0.001) and differed according to the area of habits and level of education (p < 0.001, for all). Photosensitivity was characterized by a wide range of clinical manifestations (both cutaneous and systemic symptoms in 56.1% and systemic symptoms only in 29.8% of patients). Fatigue was the most frequently reported systemic manifestation (82.3%). Overall, 559/600 (93%) patients were aware of the detrimental role of UV exposure in lupus erythematosus, but 160/480 (33.3%) were unaware of the importance of photoprotective measures, including 90/310 (29%) among those with photosensitivity.
    Conclusion: A high rate of self-reported photosensitivity characterize lupus erythematosus patients. Photosensitivity frequently includes subjective features, which makes it difficult to evaluate in clinical practice. As fatigue is frequent in LE, further study is needed to clarify its causal link with UV exposure. About one-third of lupus erythematosus patients are unaware of the importance of photoprotective measures. This should be improved through more frequent and targeted awareness interventions.
    Language English
    Publishing date 2023-10-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/kead548
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Two cases of dupilumab-responsive Kimura disease.

    Battesti, Gilles / Jachiet, Marie / Lepelletier, Clémence / Petit, Antoine / Vignon-Pennamen, Marie-Dominique / Cassius, Charles / de Masson, Adèle / Battistella, Maxime / Bagot, Martine / Bouaziz, Jean David / Mahévas, Thibault

    Clinical and experimental dermatology

    2023  Volume 49, Issue 5, Page(s) 502–506

    Abstract: Kimura disease (KD) is a rare, chronic angiolymphoproliferative inflammatory disease appearing to be mostly restricted to the skin and soft tissue. Cutaneous involvement of KD includes head and/or neck nodules showing suggestive histological features, ... ...

    Abstract Kimura disease (KD) is a rare, chronic angiolymphoproliferative inflammatory disease appearing to be mostly restricted to the skin and soft tissue. Cutaneous involvement of KD includes head and/or neck nodules showing suggestive histological features, frequently associated with an atopic dermatitis-like or prurigo-like presentation. KD is challenging to treat, with high rate of recurrence using current therapeutic strategies. Evidence for involvement of a T-helper type 2 (Th2) immune response in KD pathogenesis has been found in previous studies. Consequently, this study aimed to determine the efficacy and safety of dupilumab, a human monoclonal antibody that inhibits signalling of key Th2 cytokines, interleukin (IL)-4 and IL-13, within a single-centre cohort of patients with cutaneous KD. Two adults with a diagnosis of refractory (failure of at least one treatment line) cutaneous-restricted KD based on clinical, biological, histological, molecular and imaging findings received dupilumab for KD, and showed dramatic response with a good safety profile.
    MeSH term(s) Humans ; Antibodies, Monoclonal, Humanized/therapeutic use ; Male ; Adult ; Kimura Disease/drug therapy ; Kimura Disease/pathology ; Middle Aged ; Female ; Treatment Outcome ; Interleukin-4 ; Interleukin-13/antagonists & inhibitors
    Chemical Substances Antibodies, Monoclonal, Humanized ; dupilumab (420K487FSG) ; Interleukin-4 (207137-56-2) ; Interleukin-13
    Language English
    Publishing date 2023-12-27
    Publishing country England
    Document type Journal Article ; Case Reports
    ZDB-ID 195504-4
    ISSN 1365-2230 ; 0307-6938
    ISSN (online) 1365-2230
    ISSN 0307-6938
    DOI 10.1093/ced/llad455
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Intravascular relapse of an extra-nodal NK/T-cell lymphoma, nasal-type, presenting as diffuse and eruptive telangiectasia.

    Battesti, Gilles / Mahevas, Thibault / Lepelletier, Clemence / Teboul, Alexandre / Renaud, Loic / Moulonguet, Isabelle / Vignon-Pennamen, Marie-Dominique / Battistella, Maxime / Ram-Wolff, Caroline / Bagot, Martine / de Masson, Adèle

    European journal of cancer (Oxford, England : 1990)

    2021  Volume 156 Suppl 1, Page(s) S63–S64

    Language English
    Publishing date 2021-11-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 82061-1
    ISSN 1879-0852 ; 0277-5379 ; 0959-8049 ; 0964-1947
    ISSN (online) 1879-0852
    ISSN 0277-5379 ; 0959-8049 ; 0964-1947
    DOI 10.1016/S0959-8049(21)00745-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.

    Cohen, Elisabeth / Bozonnat, Alizée / Battistella, Maxime / Calvani, Julien / Vignon-Pennamen, Marie-Dominique / Rivet, Jacqueline / Moins-Teisserenc, Hélène / Ta, Van-Anh / Ram-Wolff, Caroline / Bouaziz, Jean-David / Mahevas, Thibault / Bagot, Martine / Mourah, Samia / Louveau, Baptiste / Sicre de Fontbrune, Flore / Peffault de Latour, Regis / de Masson, Adèle / Battesti, Gilles

    Journal of the European Academy of Dermatology and Venereology : JEADV

    2023  Volume 38, Issue 1, Page(s) e32–e34

    MeSH term(s) Humans ; Bronchiolitis Obliterans Syndrome ; Neoplasm Recurrence, Local ; Nitriles ; Lymphoma, T-Cell, Cutaneous/drug therapy ; Graft vs Host Disease/drug therapy ; Graft vs Host Disease/etiology ; Hematopoietic Stem Cell Transplantation ; Retrospective Studies ; Chronic Disease
    Chemical Substances ruxolitinib (82S8X8XX8H) ; Nitriles
    Language English
    Publishing date 2023-08-23
    Publishing country England
    Document type Letter
    ZDB-ID 1128828-0
    ISSN 1468-3083 ; 0926-9959
    ISSN (online) 1468-3083
    ISSN 0926-9959
    DOI 10.1111/jdv.19408
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study Group.

    Battesti, Gilles / Ram-Wolff, Caroline / Dobos, Gabor / Aubin, François / Algros, Marie-Paule / Guenova, Emmanuella / Joly, Pascal / Courville, Philippe / Mourah, Samia / Cayuela, Jean-Michel / Bouaziz, Jean-David / Moins-Teisserenc, Hélène / Battistella, Maxime / Vignon-Pennamen, Marie-Dominique / Rivet, Jacqueline / Bagot, Martine / de Masson, Adèle

    The British journal of dermatology

    2022  Volume 187, Issue 5, Page(s) 790–793

    MeSH term(s) Humans ; Lymphoma, T-Cell, Cutaneous/diagnosis ; Lymphoma, T-Cell, Cutaneous/therapy ; Lymphoma, T-Cell, Cutaneous/pathology ; Mycosis Fungoides/pathology ; Skin Neoplasms/diagnosis ; Skin Neoplasms/therapy ; Skin Neoplasms/pathology ; Skin/pathology ; Prognosis
    Language English
    Publishing date 2022-07-04
    Publishing country England
    Document type Letter
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1111/bjd.21699
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study.

    Battesti, Gilles / Garcia, Charline / Viguier, Manuelle / Marchal, Valentine / Castel, Marion / Joly, Pascal / Ledard, Anne-Pham / Konstantinou, Maria-Polina / Seta, Vannina / Cordel, Nadège / Duvert-Lehembre, Sophie / Tancrède-Bohin, Emmanuelle / Belmondo, Thibaut / Ingen-Housz-Oro, Saskia / d'Incan, Michel

    Journal of the American Academy of Dermatology

    2022  Volume 86, Issue 6, Page(s) 1293–1300

    Abstract: Background: A high level of anti-BP180 antibodies on enzyme-linked immunosorbent assay and a persistent positive direct immunofluorescence at the end of treatment (immunologic tests, [ITs]) are predictors of relapse after treatment cessation (TC) in ... ...

    Abstract Background: A high level of anti-BP180 antibodies on enzyme-linked immunosorbent assay and a persistent positive direct immunofluorescence at the end of treatment (immunologic tests, [ITs]) are predictors of relapse after treatment cessation (TC) in patients with bullous pemphigoid.
    Objective: To evaluate the real-life impact of the immunologic-based decision of TC on the 3- and 6-month relapse rates after TC in bullous pemphigoid.
    Methods: Retrospective multicentric study included patients followed almost 6 months after TC. Patients were classified according to whether the TC decision was in accordance with the results of ITs performed during the 3 months before TC, despite the results of ITs or without ITs performed.
    Results: We included 238 patients. Three months after TC, 36 patients showed relapse: 14 of 95 patients with TC in accordance with IT results (14.7%); 5 of 21 with TC despite ITs (23.8%); and 17 of 122 with TC without ITs (13.9%; P = .5). Six months after TC, the relapse rate was 18.9%, 28.6%, and 18.9% (P = .56), respectively, in the 3 groups.
    Limitations: The retrospective design and the limited follow up.
    Conclusion: In real-life practice, in bullous pemphigoid, the 3- and 6-month relapse rates were not significantly reduced with TC decision based on results of ITs as compared with a classic clinical-based decision.
    MeSH term(s) Autoantibodies ; Autoantigens ; Enzyme-Linked Immunosorbent Assay/methods ; Humans ; Immunologic Tests ; Non-Fibrillar Collagens ; Pemphigoid, Bullous/drug therapy ; Recurrence ; Retrospective Studies ; Withholding Treatment
    Chemical Substances Autoantibodies ; Autoantigens ; Non-Fibrillar Collagens
    Language English
    Publishing date 2022-01-26
    Publishing country United States
    Document type Journal Article ; Multicenter Study
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2022.01.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Granulomatous slack skin: clinical retrospective study of 8 cases of the Cutaneous Lymphoma French Study Group.

    Battesti, Gilles / Ram-Wolff, Caroline / Dobos, Gabor / Aubin, François / Algros, Marie-Paule / Guenova, Emmanuella / Joly, Pascal / Courville, Philippe / Mourah, Samia / Cayuela, Jean-Michel / Moins-Tesserenc, Hélène / Battistella, Maxime / Vignon-Pennamen, Marie-Dominique / Rivet, Jacqueline / Bagot, Martine / de Masson, Adèle

    European journal of cancer (Oxford, England : 1990)

    2021  Volume 156 Suppl 1, Page(s) S35–S36

    Language English
    Publishing date 2021-10-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 82061-1
    ISSN 1879-0852 ; 0277-5379 ; 0959-8049 ; 0964-1947
    ISSN (online) 1879-0852
    ISSN 0277-5379 ; 0959-8049 ; 0964-1947
    DOI 10.1016/S0959-8049(21)00690-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top